Kronos Bio Inc at Goldman Sachs Global Healthcare Conference Transcript
Good afternoon. Thanks so much for joining us. We're really pleased to have the Kronos team here with us. We have Norbert Bischofberger, President and CEO; Yasir Al-Wakeel, CFO; and Jorge DiMartino, CMO and Head of Clinical Development.
Questions & Answers
So starting here, your CDK9 inhibitor is the first molecule to emerge from your SMM platform. Could you start by walking through the key takeaways from the first data release from KB-0742, as well as the broader implications for the platform as a whole?
Yeah. Thanks, Salveen. Before we start answering the question, I want to thank you and the Goldman Sachs team for having us, hosting us, at this sunny and incredibly nice place here in Southern California.
And the only other comment I would like to make, Salveen, I'm actually very happy with where we are as a company. We have three compounds in clinical
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |